SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Shlimak Anna

(Last) (First) (Middle)
720 KING STREET WEST, SUITE 320

(Street)
TORONTO A6 M5V 2T3

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/21/2020
3. Issuer Name and Ticker or Trading Symbol
Cronos Group Inc. [ CRON ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Corporate Affairs
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
COMMON SHARES 10,000 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
COMMON SHARE OPTION (right to buy) (1) 05/17/2023 COMMON SHARES 200,000 7.57(2) I Held by Athena Advisors LLC
Explanation of Responses:
1. The options were granted May 17, 2018 and vest in monthly installments over a four-year period.
2. The exercise price is expressed in Canadian dollars.
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
/s/ Xiu Ming Shum, as attorney-in-fact for Anna Shlimak 03/02/2020
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Anna Shlimak - Exhibit 24

                         Authorization and Designation
                                to Sign and File
                           Section 16 Reporting Forms


     The undersigned, an executive officer of Cronos Group Inc., a corporation
formed under the Business Corporations Act (Ontario) (the "Company"), does
hereby authorize and designate Jerry Barbato or Xiu Ming Shum, each with right
to substitute and resubstitute, but for only so long as each of them is an
officer of the Company, to sign and file on his or her behalf the application
for the required Securities and Exchange Commission ("SEC") electronic CIK/CCC
codes and any and all Forms 3, 4 and 5 and Forms 144 relating to equity
securities of the Company with the SEC pursuant to the requirements of Section
16 of the Securities Exchange Act of 1934 ("Section 16") and Rule 144 under the
Securities Act of 1933, as amended.  This authorization, unless earlier revoked
in writing, shall be valid until the undersigned's reporting obligations under
Section 16 and Rule 144 with respect to equity securities of the Company shall
cease.  All prior such authorizations are hereby revoked.

     IN WITNESS WHEREOF, the undersigned has executed this Authorization and
Designation this 27th day of February, 2020.



                                               /s/ Anna Shlimak
                                               ---------------------------------
                                               Anna Shlimak